CureDuchenne Ventures
Overview
CureDuchenne Ventures, LLC is the investment arm of CureDuchenne, a national nonprofit dedicated to curing Duchenne muscular dystrophy, the most common and lethal form of muscular dystrophy . CureDuchenne Ventures supports Duchenne research by using philanthropic donations to encourage development of new Duchenne drugs and provides both grant funding to academic groups, as well as equity financing to biotech and pharmaceutical companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Myosana Therapeutics | Jun 2025 | Crowdfunding | Co-investor |
| Phoenicis Therapeutics | Aug 2022 | VC Round | Co-investor |
| Code Biotherapeutics | Jun 2022 | Series A | - |
| Gennao Bio | Dec 2022 | Series B | Co-investor |
| Shape Therapeutics | Nov 2019 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CureDuchenne Ventures based?
CureDuchenne Ventures is headquartered in Newport Beach, California, United States.
When was CureDuchenne Ventures founded?
CureDuchenne Ventures was founded in 2014.
How many portfolio companies does CureDuchenne Ventures have?
CureDuchenne Ventures has 11 portfolio companies in Caplight's dataset.
What are some companies in CureDuchenne Ventures's portfolio?
Portfolio companies visible on Caplight include Myosana Therapeutics, Phoenicis Therapeutics, Code Biotherapeutics, Gennao Bio, Shape Therapeutics.
What was CureDuchenne Ventures's most recent investment shown here?
CureDuchenne Ventures's most recent investment in this portfolio sample was in Myosana Therapeutics in 2025.
What sectors does CureDuchenne Ventures focus on?
CureDuchenne Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does CureDuchenne Ventures focus on?
CureDuchenne Ventures typically invests at the Early stage.
What is CureDuchenne Ventures's AUM?
CureDuchenne Ventures's assets under management are estimated between $50.0M and $100.0M.